glp 1 and cancer treatment Glucagon-like peptide-1 receptor agonists risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials InsideHSC News
Description
The drug also slows down the digestive system, so you feel fuller longer
Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized obesity and type 2 diabetes medicine and alleviate many comorbidities of these metabolic diseases
How Rapid Weight Loss Increases Gallstone Risk When the body loses weight quickly, the liver releases more cholesterol into bile, and the gallbladder contracts less frequently
Duh, right
Tirzepatide (Zepbound, Mounjaro) Tirzepatide is a first-in-class dual agonist
A gradual tapering process, guided by a healthcare provider, helps prevent intense hunger, metabolism imbalances, and potential complications like blood sugar spikes in people with diabetes
